TCL Archive In Brief: Reagan Names Hammer to Third Term As Cancer Panel chairman; RPMI Opens Survivor Clinic July 31, 1987
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI February 16, 1990
TCL Archive Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies. January 13, 2006
TCL Archive DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each June 11, 1982
